Supernus Pharmaceuticals
SUPN
#4182
Rank
HK$20.38 B
Marketcap
HK$355.60
Share price
1.29%
Change (1 day)
23.54%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total debt

Total debt on the balance sheet as of September 2025 : HK$0.32 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total debt is HK$0.32 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Supernus Pharmaceuticals - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.26 B-17.96%
2023-12-31HK$0.32 B-90.67%
2022-12-31HK$3.47 B4.36%
2021-12-31HK$3.32 B3.67%
2020-12-31HK$3.21 B8.98%
2019-12-31HK$2.94 B14.24%
2018-12-31HK$2.57 B
2017-12-31N/A-100%
2016-12-31HK$32.29 M-41.18%
2015-12-31HK$54.91 M-73%
2014-12-31HK$0.20 B-23.73%
2013-12-31HK$0.26 B50.27%
2012-12-31HK$0.17 B-22.5%
2011-12-31HK$0.22 B-60.76%
2010-12-31HK$0.58 B0.37%
2009-12-31HK$0.58 B0.34%
2008-12-31HK$0.57 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
HK$1.55 B 373.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$330.89 B 100,597.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$397.33 B 120,815.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$100.74 B 30,557.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$356.49 B 108,388.11%๐Ÿ‡บ๐Ÿ‡ธ USA